Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Stent Thrombosis - VASP


Several studies have demonstrated that there is a large variation in patient response to clopidogrel. A low response rate has been linked with an increased risk of adverse outcomes, including major adverse cardiac events (MACE) and stent thrombosis. This study sought to assess the utility of a vasodilator-associated stimulated phosphoprotein (VASP) index to guide management in patients undergoing percutaneous coronary intervention (PCI) for nonemergent causes.